Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Uterine Cervical Neoplasms 1Oropharyngeal Neoplasms 1

Interventions

Cisplatin 3X-Rays 2zimberelimab 1durvalumab 1dl1520 1cemiplimab 1balstilimab 1Taxes 1Standard of Care 1Radiation 1Practice Guidelines as Topic 1Polymerase Chain Reaction 1Narrow Band Imaging 1Magnetic Resonance Spectroscopy 1MEDI0457 1Lansoprazole 1Gene Expression Profiling 1Gabapentin 1Fluorouracil 1Fluorodeoxyglucose F18 1Exercise Test 1Drug Delivery Systems 1Dexlansoprazole 1Cetuximab 1Blood Specimen Collection 1Alpelisib 1Absorptiometry, Photon 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Oropharyngeal Neoplasms × MEDI0457 × Clear all
NCT04001413 2022-07-29

Therapy for High-Risk HPV 16-Positive Oropharynx Cancer Patients

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Withdrawn
Head & Neck

Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡